期刊文献+

人工全髋关节置换术治疗骨性强直髋畸形的近期疗效 被引量:1

Total Hip Replacement for Treatment of Bony Ankylosed Hips Deformity
下载PDF
导出
摘要 目的:观察人工全髋关节置换术在治疗骨性强直髋畸形中的近期疗效。方法:收集本科自2012年9月至2013年12月采用人工全髋关节置换术治疗骨性强直髋畸形9例11髋,分别于术后1月、3月、半年、1年门诊复查,评价患者Harris评分。结果:9例骨性强直髋畸形患者均获随访,平均随访时间1.27年。术后1年Harris评分85.19±5.37分,较术前有明显改善。结论:人工全髋关节置换术在治疗骨性强直髋畸形中的近期随访疗效满意。 Objective To observe the short-term efficacy of total hip replacement for the treatment of bony ankylosed hips deformity by follow-up. Methods The clinical data of 9 patients with 11 hips were collected. The Harris scale of patients were evaluated at 1 month,3 month,half year and 1 year after total hip replacement,respectively. Results All the patients were followed up,the mean duration of follow-up was 1. 27 years. According to the scale of Harris,the mean hip score was 85. 19± 5. 37 at 1 year post-operation follow-up,which was significantly higher than that pre-operation. Conclusion Total hip replacement is a short-term effective treatment indicated for bony ankylosed hips deformity,but it need further confirm its long-term effectiveness by follow-up.
出处 《湖北医药学院学报》 CAS 2015年第3期232-235,F0003,共5页 Journal of Hubei University of Medicine
基金 湖北省科学技术厅资助项目(2013CFC031) 湖北省卫生计生科研基金资助项目(WJ2015Q042)
关键词 全髋关节置换术 骨性强直髋 畸形 Total hip replacement Bony ankylosed hip Deformity
  • 相关文献

参考文献11

  • 1Hu Y, Wang S, Wu X, et al. Chinese herbal medicine- derived compounds for cancer therapy:a focus on hepa- tocellular carcinoma [ J ]. J Ethnopharmacol, 2013,149 (3) :601 -612.
  • 2Zhang F, Liu J, Shi JS. Anti-inflammatory activities of resveratrol in the brain:role of resveratrol in microglial activation [ J ]. Eur J Pharmacol, 2010,636 ( 1/3 ) : 1 - 7.
  • 3Piotrowska H, Kucinska M, Murias M. Biological activity of piceatannol : leaving the shadow of resveratrol [ J ]. Mutat Res ,2012,750( 1 ) :60 - 82.
  • 4Yang XH, Feng ZE, Yan M, et al. XIAP is a predictor of cisplatin-based chemotherapy response and prognosis for patients with advanced head and neck cancer [ J ]. PLoS One,2012,7(3 ) :e31 601.
  • 5马晓洁,李杰,谭榜宪.原发性肝癌切除术后预后因素及生存分析[J].肿瘤研究与临床,2013,25(9):588-590. 被引量:4
  • 6Huynh C, Hung P, Yang LX. Improved chemotherapy for hepatocellular carcinoma [ J ]. Anticancer Res, 2012,32 (4) :1 379-1 386.
  • 7Carr BI. Hepatocellular carcinoma:current management and future trends [ J ]. Gastroenterology, 2004, 127 ( 5 Suppl 1) :$218 - $224.
  • 8Xu Y, Wang C, Li Z. A new strategy of promoting cispl- atin chemotherapeutic efficiency by targeting endoplas- mic reticulum stress [ J ]. Mol Clin Oncol,2014,2 ( 1 ) :3 -7,.
  • 9Rezk YA, Balulad SS, Keller RS, et al. Use of resvera- trol to improve the effectiveness of cisplatin and doxoru- bicin. Study in human gynecologic cancer cell lines and in rodent heart [ J ]. Am J Obstet Gynecol, 2006,194, e23 - e26.
  • 10Farrand L, Byun S, Kim JY, et al. Pieeatannol enhances cisplatin sensitivity in ovarian cancer via modulation of p53, X-linked inhibitor of apoptosis protein ( XIAP), and mitochondrial fission [ J ]. J Biol Chem, 2013,288 (33) :23 740 -23 750.

二级参考文献7

共引文献3

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部